The Guizhou snub-nosed monkey, Rhinopithecus brelichi, is a large-bodied colobine confined to the subtropical semideciduous forests of Fanjing Mountain Reserve in Guizhou province, southwest China. Field work beginning in 1979 and including 10 months of intensive study in 1991 has revealed several aspects of the behavior and ecology of this species that are distinct from other colobines, including the closely related species R. roxellana and R. bieti. The Guizhou snub-nosed monkey is arboreal, traveling through the trees by quadrupedal walking, climbing, leaping, semibrachiation and (occasionally) by full brachiation. Terrestrial locomotion is used occasionally. Social organization centers around family groups of 5–10 individuals with a single adult male. Many family groups range and rest together in large, semicohesive bands. These bands may split up or coalesce temporarily to form large aggregations of over 400 animals and perhaps more. All-male groups of 2–5 adult or subadult males are found on the periphery of the bands.

Keywords:
Golden monkey, Snub-nosed langur, Pygathrix, Field study, Social behavior, Brachiation, Rhinopithecus brelichi
This content is only available via PDF.
© 1993 S. Karger AG, Basel
1993
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.